Genetic polymorphisms in matrix metalloproteinases ( MMPs ) and tissue inhibitors of MPs ( TIMPs ), and bladder cancer susceptibility
- 14 May 2013
- journal article
- translational science
- Published by Wiley in BJU International
- Vol. 112 (8) , 1207-1214
Abstract
Objectives: To elucidate genetic polymorphisms of the matrix metalloproteinases ( MMPs ) MMP 1 (rs1799750) , MMP 2 (rs243865) , MMP 9 (rs3918242) , MMP 12 (rs2276109) and tissue inhibitors of MMPs ( TIMPs ) TIMP 1 (rs2070584) and TIMP 3 (rs9619311) genes that may be involved in susceptibility to bladder cancer ( BC ). Patients and Methods: We enrolled 241 patients with BC and 199 controls. Genomic DNA samples were extracted from peripheral blood and polymorphisms were analysed by high‐resolution melting analysis and by real‐time polymerase chain reaction using T aq M an fluorescent probes. Results: Of the six evaluated polymorphisms of MMPs and TIMPs , only one was found to be associated with BC risk. There was a significant difference for MMP 1 (rs1799750) 2 G /1 G +1 G /1 G genotype (odds ratio [ OR ] 0.62, 95% confidence interval [ CI ] 0.39–0.98; P = 0.042). Additionally, there was a joint effect of this genotype on BC risk among ‘ever smokers’ ( OR 0.51, 95% CI 0.28–0.89; P = 0.019), but not in ‘never smokers’. The combined genotype MMP 2 –1306 C / T (rs243865) allele T with MMP 9 –1562 C / T (rs3918242) allele T was found to increase BC risk ( OR 2.00, 95% CI 1.10–3.62; P = 0.022). Conclusions: Our results suggest that genetic variations in five polymorphisms of MMPs and TIMPs are not associated with a high risk of BC . Only MMP 1 polymorphism may be related to the risk of BC , notably in ‘ever smokers’. Our study suggests that the effects of polymorphisms of MMPs and TIMPs on BC risk deserve further investigation.Keywords
This publication has 49 references indexed in Scilit:
- Genetic polymorphism of matrix metalloproteinases in breast cancerNeoplasma, 2012
- Polymorphisms in tissue inhibitors of metalloproteinases‐2 and ‐3 and breast cancer susceptibility and survivalInternational Journal of Cancer, 2009
- No Association betweenMatrix Metalloproteinase-1orMatrix Metalloproteinase-3Polymorphisms and Breast Cancer Susceptibility: A Report from the Shanghai Breast Cancer StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancerEuropean Journal of Cancer, 2007
- The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancerBritish Journal of Cancer, 2007
- Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary resultsBreast Cancer Research and Treatment, 2007
- Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progressionBreast Cancer Research and Treatment, 2006
- Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer developmentBritish Journal of Cancer, 2003
- ROLE OF MATRIX METALLOPROTEINASE-9 IN THE BASEMENT MEMBRANE DESTRUCTION OF SUPERFICIAL UROTHELIAL CARCINOMASJournal of Urology, 1999
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990